Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA1c in Type 2 Diabetes: A Randomized-Controlled Trial in a Real-Life Setting
Nutrients · 2023
DOI: 10.3390/nu15183954 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Kerstin Kempf und 8 weiteren Autor:innen. Beteiligte Einrichtung: West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, 40591 Düsseldorf, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation Funds of the German Federal Ministry of Health, German Federal Ministry of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The effectiveness of the multimodal Telemedical Lifestyle Intervention Program (TeLIPro) was proven in the advanced stages of type 2 diabetes mellitus (T2DM). Since its therapeutic potential focusing on telemedical coaching without using a formula diet is unknown, we evaluated improvements in HbA1c, HbA1c normalisation rate, cardiometabolic risk factors, quality-of-life, and eating behaviour in real life. In this randomized-controlled trial, AOK Rhineland/Hamburg insured T2DM patients (n = 1163) were randomized (1:1) into two parallel groups, and 817 received the allocated intervention. In addition to routine care, all participants got scales, step counters, and access to an online portal. The TeLIPro group additionally received equipment for self-monitoring of blood glucose and telemedical coaching. Data were collected at baseline, after 6 and 12 months of intervention as well as after a 6-month follow-up. The primary endpoint after 12 months was (i) the estimated treatment difference (ETD) in HbA1c change and (ii) the HbA1c normalisation rate in those with diabetes duration < 5 years. The TeLIPro group demonstrated significantly stronger improvements in HbA1c (ETD −0.4% (−0.5; −0.2); p < 0.001), body weight, body-mass-index, quality-of-life, and eating behaviour, especially in T2DM patients with diabetes duration ≥ 5 years (ETD −0.5% (−0.7; −0.3); p < 0.001). The HbA1c normalisation rate did not significantly differ between groups (25% vs. 18%). Continuous addition of TeLIPro to routine care is effective in improving HbA1c and health-related lifestyle in T2DM patients with longer diabetes duration in real life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, 40591 Düsseldorf, Germany.
- inav-Private Institute for Applied Health Services Research GmbH, 10117 Berlin, Germany.
- German Institute for Telemedicine and Healthcare (DITG) GmbH, 40591 Düsseldorf, Germany.
- General Health Insurance Scheme (AOK Rheinland/Hamburg-Die Gesundheitskasse), 40213 Düsseldorf, Germany.
- Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
- Institute for Health Services Research and Health Economics, Centre for Health and Society, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
ORCID-Profile: Kerstin Kempf
Förderung
- Innovation Funds of the German Federal Ministry of Health
- German Federal Ministry of Health
Zitieren
APA
Kempf, K., Dubois, C., Arnold, M., Amelung, V., Leppert, N., Altin, S., Vomhof, M., Icks, A., & Martin, S. (2023). Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA1c in Type 2 Diabetes: A Randomized-Controlled Trial in a Real-Life Setting. Nutrients. https://doi.org/10.3390/nu15183954
Vancouver
Kempf K, Dubois C, Arnold M, Amelung V, Leppert N, Altin S, et al. Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA1c in Type 2 Diabetes: A Randomized-Controlled Trial in a Real-Life Setting. Nutrients. 2023. doi:10.3390/nu15183954
BibTeX
@article{Kempf2023,
author = {Kempf, Kerstin and Dubois, Clara and Arnold, Matthias and Amelung, Volker and Leppert, Nora and Altin, Sibel and Vomhof, Markus and Icks, Andrea and Martin, Stephan},
title = {Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA1c in Type 2 Diabetes: A Randomized-Controlled Trial in a Real-Life Setting},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15183954}
}
EUVIMED